| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |